Vaccines
Scientists and Experts
Anne Katrin Hilbert
Luc Gagnon
Steven-Phay Tran
Marie-Christine Locas
Deborah Wrona
Matthieu Daugan, Director of the Cell-Mediated Immunity Platform at IQVIA Laboratories, delves into his background in immunology and virology, the intricacies of his current role, and the challenges and advancements in the field of vaccine development. Matthieu shares insights into the complexity of cell-mediated immunity, the importance of detailed scientific analysis, and the evolution of vaccine evaluation, particularly in light of recent global health challenges such as COVID-19. This discussion provides a comprehensive overview of the processes involved in analyzing immune responses and the significance of his team’s work at different stages of vaccine development.
Take a look at the in-depth processes and roles within our laboratory team, focusing on the experiences and responsibilities of Valérie Gauthier, an Associate Director. Valerie discusses her career journey, team dynamics, sample management procedures, the importance of maintaining the chain of custody, and the integration of a LIMS system to enhance efficiency and accuracy in the lab. The detailed descriptions highlight the critical role her team plays in the beginning and end stages of sample processing, as well as the challenges and achievements in their work.
Azriel Lopez, our Associate Manager of lab operations, discusses his role and journey in cell culture. He explains how his background in biotech engineering and his interest in tissue culture led him to his current position. Azriel provides a detailed overview of the cell culture process, its applications in vaccine validation, and his team's efforts to scale up cell production.
Cedric Hupperetz, a scientist in the Bacteriology Research and Development division, shares his journey and current role in optimizing immunoassays for vaccine efficacy. He discusses his educational background, his passion for health sciences, and his specialized work with the Multiplexed Opsonophagocytic Assay. Cedric provides insights into the challenges of vaccine development, the clinical trial process, and the collaborative efforts of his dedicated team.
Marie-Noel Lepage, Manager in Assay Development, shares her extensive experience and passion for Virology and lab work. With a background in Cellular Molecular Biology from Concordia University and over 20 years in the CRO world, Marie-Noel has played a crucial role in preclinical and clinical testing, specializing in Neutralization Assays and Vaccine Development. She discusses her career journey, the impact of her work in drug and vaccine development, and the specific processes involved in creating and validating tests, including significant contributions during the COVID-19 pandemic.
